IVERIC bio (ISEE) Tops Q3 EPS by 5c

IVERIC bio (NASDAQ: ISEE) reported Q3 EPS of ($0.35), $0.05 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on IVERIC bio (ISEE) click here.

You May Also Be Interested In

• Solstice acquiring Element Solutions in $14.5B cash and stock deal
• Incyte acquires Vega Therapeutics for $1.25B upfront
• Innovative Eyewear posts 71% sales gain, adds retail partners